156 related articles for article (PubMed ID: 29625856)
1. Characteristics and outcomes of reversed patients admitted to an emergency department for VKA-related intramuscular hematoma.
Moustafa F; Poujol L; Vincent N; Saint-Denis J; Dublanchet N; Breuil N; Heuser S; Lebreton A; Dutheil F; Schmidt J
Am J Emerg Med; 2018 Jul; 36(7):1257-1261. PubMed ID: 29625856
[TBL] [Abstract][Full Text] [Related]
2. Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation.
De Heide J; Vroegh CJ; Bhagwandien RE; Wijchers SA; Szili-Torok T; Zijlstra F; Lenzen MJ; Yap SC
J Interv Card Electrophysiol; 2018 Dec; 53(3):341-346. PubMed ID: 30074120
[TBL] [Abstract][Full Text] [Related]
3. Conservative treatment of large rectus sheath hematoma in patients undergoing anticoagulant therapy.
Berná JD; Zuazu I; Madrigal M; García-Medina V; Fernández C; Guirado F
Abdom Imaging; 2000; 25(3):230-4. PubMed ID: 10823439
[TBL] [Abstract][Full Text] [Related]
4. [Rectus sheath hematoma: a rarely diagnosed complication of anticoagulation therapy].
Elikowski W; Małek M; Klich A; Wróblewski D; Gizło J
Pol Merkur Lekarski; 2012 May; 32(191):309-12. PubMed ID: 22779338
[TBL] [Abstract][Full Text] [Related]
5. Treatment With Prothrombin Complex Concentrate to Enable Emergency Lumbar Puncture in Patients Receiving Vitamin K Antagonists.
Laible M; Beynon C; Sander P; Purrucker J; Müller OJ; Möhlenbruch M; Ringleb PA; Rizos T
Ann Emerg Med; 2016 Sep; 68(3):340-4. PubMed ID: 27085368
[TBL] [Abstract][Full Text] [Related]
6. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates.
Huttner HB; Schellinger PD; Hartmann M; Köhrmann M; Juettler E; Wikner J; Mueller S; Meyding-Lamade U; Strobl R; Mansmann U; Schwab S; Steiner T
Stroke; 2006 Jun; 37(6):1465-70. PubMed ID: 16675739
[TBL] [Abstract][Full Text] [Related]
7. Acute, major muscular hematoma associated with antithrombotic agents: A multicenter real-world cohort.
Bouget J; Huet MC; Roy PM; Viglino D; Lacut K; Pavageau L; Oger E
Thromb Res; 2021 Mar; 199():54-58. PubMed ID: 33429124
[TBL] [Abstract][Full Text] [Related]
8. Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate.
Majeed A; Meijer K; Larrazabal R; Arnberg F; Luijckx GJ; Roberts RS; Schulman S
Thromb Haemost; 2014 Feb; 111(2):233-9. PubMed ID: 24154891
[TBL] [Abstract][Full Text] [Related]
9. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
Le Roux P; Pollack CV; Milan M; Schaefer A
J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
[TBL] [Abstract][Full Text] [Related]
10. Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants. Results from the Dresden NOAC registry.
Michalski F; Tittl L; Werth S; Hänsel U; Pannach S; Sahin K; Weiss N; Beyer-Westendorf J
Thromb Haemost; 2015 Nov; 114(5):1076-84. PubMed ID: 25994496
[TBL] [Abstract][Full Text] [Related]
11. Randomised controlled trial protocol to evaluate a fixed dose prothrombin complex concentrate against the variable dose in vitamin K antagonist related bleeding (PROPER3).
Abdoellakhan RA; Khorsand N; Van Hest RM; Veeger N; Ter Avest E; Ypma PF; Faber LM; Meijer K
BMJ Open; 2018 Mar; 8(3):e020764. PubMed ID: 29540424
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulant-Related Intramuscular Hematomas in an Inpatient Acute Rehabilitation Population: A Case Series.
Kallas PG; Zalinger M; Sliwa JA; Eskandari MK
Am J Phys Med Rehabil; 2022 Jan; 101(1):e11-e14. PubMed ID: 34483262
[TBL] [Abstract][Full Text] [Related]
13. Clinical management and outcome of major bleeding in patients on treatment with vitamin K antagonists.
Becattini C; Franco L; Masotti L; Nitti C; Cattinelli S; Cappelli R; Manina G; Sbrojavacca R; Pomero F; Agnelli G
Eur J Intern Med; 2016 Sep; 33():47-54. PubMed ID: 27289494
[TBL] [Abstract][Full Text] [Related]
14. Does IV contrast extravasation on CT in anticoagulant-related rectus sheath and iliopsoas hematoma predict hematoma expansion and patient outcomes?
Landecy M; Paquette B; Revel L; Behr J; Badet N; Delabrousse E
Abdom Radiol (NY); 2016 Nov; 41(11):2241-2247. PubMed ID: 27405643
[TBL] [Abstract][Full Text] [Related]
15. Risk factors of vitamin K antagonist overcoagulation. A case-control study in unselected patients referred to an emergency department.
Cadiou G; Varin R; Levesque H; Grassi V; Benichou J; Tiret I; Dieu B; Lecam-Duchez V; Borg JY; Muller JM; Benhamou Y; Marie I
Thromb Haemost; 2008 Oct; 100(4):685-92. PubMed ID: 18841293
[TBL] [Abstract][Full Text] [Related]
16. Chronic vitamin K antagonist therapy and bleeding risk in ST elevation myocardial infarction patients.
Karrowni W; Wang TY; Chen AY; Thomas L; Saucedo JF; El Accaoui RN
Heart; 2015 Feb; 101(4):264-70. PubMed ID: 25336230
[TBL] [Abstract][Full Text] [Related]
17. Hospitalization for vitamin-K-antagonist-related bleeding: treatment patterns and outcome.
Halbritter K; Beyer-Westendorf J; Nowotny J; Pannach S; Kuhlisch E; Schellong SM
J Thromb Haemost; 2013 Apr; 11(4):651-9. PubMed ID: 23347087
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of intraparenchymal hemorrhage after direct oral anticoagulant or vitamin K antagonist therapy: A systematic review and meta-analysis.
DiRisio AC; Harary M; Muskens IS; Yunusa I; Gormley WB; Aglio LS; Smith TR; Connors JM; Mekary RA; Broekman MLD
J Clin Neurosci; 2019 Apr; 62():188-194. PubMed ID: 30472344
[TBL] [Abstract][Full Text] [Related]
19. Acute subdural hematoma in patients on oral anticoagulant therapy: management and outcome.
Won SY; Dubinski D; Bruder M; Cattani A; Seifert V; Konczalla J
Neurosurg Focus; 2017 Nov; 43(5):E12. PubMed ID: 29088960
[TBL] [Abstract][Full Text] [Related]
20. [Vitamin K antagonist overdose induced blindness in an infant: an argument for a therapeutic educational program].
Bui Quoc E; Bonnet D; Bajolle F
Arch Pediatr; 2012 Jan; 19(1):22-6. PubMed ID: 22169573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
